Long-term dosing with lucerastat, an experimental substrate reduction treatment from Idorsia, may slow the loss of kidney function…
Articles by Margarida Maia, PhD
Fabry disease takes a significant toll on the hearts of both male and female patients in Finland, often leading…
Renal cell carcinoma, a common type of kidney cancer, is diagnosed more frequently in people with Fabry disease than…
All patients who have so far received the gene therapy candidate ST-920 (isaralgagene civaparvovec) — being developed by…
A woman with heart failure due to late-onset Fabry disease received a heart transplant in combination with immunosuppressants and…
A kidney biopsy can be important in diagnosing Fabry disease because it can confirm or rule out the condition…
AL01211Â may help stabilize symptoms in men with Fabry disease, while easing pain and improving quality of life, according…
SGLT2 inhibitors, medications approved for diabetes, could be used in Fabry disease to reduce albuminuria, which occurs when damaged…
A machine learning algorithm to find patterns in data from infrared spectroscopy — a technique that can provide a molecular…
Treatment with Elfabrio (pegunigalsidase alfa), given at more spaced intervals and at a higher dose than that approved for…